RemSleep Holdings Inc. (RMSL)
OTC PINK OTC PINK Primary Summary
REMSleep Holdings Inc. Issues Shareholder Letter
Company Unveils Internal Corporate Goal of Capturing 10% of the CPAP Mask Market Within 24 Months CLEARWATER, Fla., August 6, 2024 – REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, published the following letter to shareholders.
REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples
Clearwater, FL, July 24, 2024 – REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, is thrilled to announce that a significant distributor in the CPAP industry has requested samples of its new nasal interface, the DELTAWAVE Nasal Pillows System.
REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System
Clearwater, FL, July 17, 2024– REMSleep Holdings Inc. (OTCQB: RMSL), a pioneer in sleep apnea treatment solutions, is thrilled to announce a comprehensive marketing strategy for its revolutionary DELTAWAVE Nasal Pillows System.
RemSleep Holdings Inc. (RMSL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has RemSleep Holdings Inc. ever had a stock split?
RemSleep Holdings Inc. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Sanja Pekovic CEO | OTC PINK Exchange | 75990A200 CUSIP |
| US Country | 2 Employees | - Last Dividend | 26 Mar 2015 Last Split | - IPO Date |
Overview
REMSleep Holdings, Inc. is a company dedicated to improving the lives of individuals affected by sleep apnea on a global scale. Headquartered in Tampa, Florida, REMSleep Holdings, Inc. has set its sights on the development and distribution of innovative products designed specifically for the sleep apnea market. The organization caters to a broad audience, including home care dealers, private sleep laboratories, product end users, as well as medical professionals and institutions like physicians, medical groups, and hospitals. Additionally, it maintains a relationship with various medical associations, positioning itself as a key player in the sleep apnea treatment ecosystem.
Products and Services
- DeltaWave CPAP Interface Device:
The DeltaWave CPAP Interface Device is REMSleep Holdings, Inc.'s flagship product, aimed at treating patients suffering from sleep apnea. This innovative device stands out for its unique approach to providing Continuous Positive Airway Pressure (CPAP), designed to ensure that users experience a comfortable and effective treatment. Tailored to meet the needs of individuals struggling with sleep apnea, the DeltaWave device exemplifies REMSleep’s commitment to elevating the standard of care in sleep therapy through advanced technology and patient-centric design.
